REFERENCES
- Burton J L, Shuster S. Large doses of glucocorticoid in the treatment of alopecia areata. Acta Derm Venereol (Stockh) 1975; 55: 493–6
- Johnson R B, Lazarus G S. Pulse therapy: therapeutic efficacy in the treatment of pyoderma gangrenosum. Arch Dermatol 1982; 118: 76–84
- Seigel J, Eaglstein W H. High-dose methylprednisolone in the treatment of bullous pemphigoid. Arch Dermatol 1984; 120: 1157–65
- Snyder R A, Schwartz R A, Schneider J S, et al. Intermittent megadose corticosteroid therapy for generalized lichen planus. J Am Acad Dermatol 1982; 6: 1089–90
- Fine J D, Appell M L, Green L K, et al. Pemphigus vulgaris: combined treatment with intravenous corticosteroid pulse therapy, plasmapheresis, and azathioprine. Arch Dermatol 1988; 124: 236–9
- Case J D, Smith S Z, Callen J P. The use of pulse methylprednisolone and chlorambucil in the treatment of Sweet's syndrome. Cutis 1989; 44: 125–9
- Sherertz E F, Jegasothy B V, Lazarus G S. Phenytoin hypersensitivity reaction presenting with toxic epidermal necrolysis and severe hepatitis. J Am Acad Dermatol 1985; 12: 178–81
- Prystowky J H, Kahn S N, Lazarus G S. Present status of pyoderma gangrenosum: review of 21 cases. Arch Dermatol 1989; 125: 57–64
- Resnik B I, Rendon M, Kerdel F A. Successful treatment of aggressive pyoderma gangrenosum with pulse steroids and chlorambucil. J Am Acad Dermatol 1992; 27: 635–6
- Pasricha J S, Thanzama J, Uttam Kumar Khan. Intermittent high-dose dexamethasone-cyclophosphamide therapy for pemphigus. Br J Dermatol 1988; 119: 73–7
- Laszlo K S, Falanga V, Kerdel F A. Idiopathic palmar fasciitis. Int J Dermatol 1995; 34(9)658–60
- Gurwitz J H, Bohn R L, Glynn R J, et al. Glucocorticoids and the risk for initiation of hypoglycemic therapy. Arch Intern Med 1994; 154: 97–101
- Moses R E, McCormick A, Nickey W. Fatal arrhythmia after pulse methylprednisolone therapy. Ann Intern Med 1981; 95: 781–2, (letter).
- Belmonte M A, Cequiere A, Roig-Escofet D. Severe ventricular arrhythmia after methylprednisolone pulse therapy in rheumatoid arthritis. J Rheumatol 1986; 13: 477–9, (letter).
- Chikanza I C, Fernandes L. Arrhythmia after pulse methylprednisolone therapy. Br J Rheumatol 1991; 30: 392–3, (letter).
- Barrett D F. Pulse methylprednisolone therapy. Lancet 1983; 2: 800, (letter).
- Gardiner P VG, Griffiths I D. Sudden death after treatment with pulse methylprednisolone. Br J Rheumatol 1990; 300: 125, (letter).
- Thompson J F, Chalmers D H, Wood R F, et al. Sudden death following high-dose intravenous methylprednisolone. Transplantation 1983; 36: 594–6
- Boscanegra T S, Castaneda M O, Espinoza L R, et al. Sudden death after methylprednisolone pulse therapy. Ann Intern Med 1981; 95: 122
- White K P, Driscoll M S, Roth M J, et al. Several adverse cardiovascular effects of pulse steroid therapy: is continuous cardiac monitoring necessary?. J Am Acad Dermatol 1994; 30: 768–73